|
|
||||||||
Clinical Chemistry, Vol 39, 2470-2477, Copyright © 1993 by American Association for Clinical Chemistry
R Djurup, C Chiabrando, A Jorres, R Fanelli, M Foegh, HU Soerensen and PN Joergensen
Novo Nordisk, Immunochemical Department, Bagsvaerd, Denmark.
We have developed a direct enzyme immunoassay (EIA) for quantifying immunoreactive 11-keto-thromboxane B2 (iKTXB) in unprocessed human urine. Cross-reactivity with other thromboxane metabolites and prostanoids was negligible. Analytical recovery of 11-keto-TXB2 in urine specimens was 97.4% to 99.8%. Total imprecision for two clinical specimens was 8.5% and 12.2%. Intake of acetylsalicylic acid decreased the measured concentration of iKTXB. Cardiopulmonary bypass, a procedure known to activate platelets, increased the mean excretion rate of iKTXB 10-fold. Simultaneous gas chromatography-mass spectrometry analysis of 11-keto-TXB2 and 11-keto-2,3-dinor TXB2 in urine specimens (n = 17) from healthy subjects indicated that urinary iKTXB concentrations measured by EIA represented a sum of the two 11- keto metabolites. We conclude that the direct EIA is sufficiently sensitive, rapid, simple, and specific to allow screening for alterations in thromboxane biosynthesis in patients.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. Bruno, J. P. McConnell, S. N. Cohen, G. E. Tietjen, R. A. Wallis, P. B. Gorelick, and N. U. Bang Serial Urinary 11-Dehydrothromboxane B2, Aspirin Dose, and Vascular Events in Blacks After Recent Cerebral Infarction Stroke, March 1, 2004; 35(3): 727 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bruno, J. P. McConnell, H. H. Mansbach, III, S. N. Cohen, G. E. Tietjen, and N. U. Bang Aspirin and Urinary 11-Dehydrothromboxane B2 in African American Stroke Patients Stroke, January 1, 2002; 33(1): 57 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P Mensink, A. C van Houwelingen, D. Kromhout, and G. Hornstra A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations Am. J. Clinical Nutrition, February 1, 1999; 69(2): 213 - 219. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |